Completed PHASE4 INTERVENTIONAL 1-arm NCT01256021

The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy

Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MEDITOXIN® in Children With Cerebral Palsy

Sponsor: Medy-Tox

Conditions Muscle Spasticity

Interventions Botulinum Toxin Type A

Updated 7 times since 2017 Last updated: Mar 25, 2019 Started: Aug 31, 2010 Primary completion: Feb 28, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01256021, this PHASE4 trial focuses on Muscle Spasticity and remains completed. Sponsored by Medy-Tox, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Apr 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Jun 2018 — Apr 2019 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medy-Tox

Data source: Medy-Tox

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seongnam, South Korea
• Seoul, South Korea